Connect Biopharma Holdings Limited Operating Lease, Payments
Connect Biopharma Holdings Limited (CNTB) reported Operating Lease, Payments of $111.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-08-12
- Connect Biopharma Holdings Limited operating lease, payments for the quarter ending 2026-06-30 was $111.00K, a 26.14% increase year-over-year.
- Connect Biopharma Holdings Limited operating lease, payments for the quarter ending 2026-03-31 was $109.00K, a 43.42% increase year-over-year.
- Connect Biopharma Holdings Limited operating lease, payments for the quarter ending 2025-12-31 was $131.00K, a 74.67% increase year-over-year.
- Connect Biopharma Holdings Limited operating lease, payments for the quarter ending 2025-09-30 was $106.00K, a 39.47% increase year-over-year.
- Connect Biopharma Holdings Limited operating lease, payments for fiscal 2025 was $400.00K, a 33.33% increase from fiscal 2024.
- Connect Biopharma Holdings Limited operating lease, payments for fiscal 2024 was $300.00K, a 0.00% change from fiscal 2023.
- Connect Biopharma Holdings Limited operating lease, payments for fiscal 2023 was $300.00K.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 3 month as first filed | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $111.00K 10-Q · filed 2026-08-12 | $220.00K 10-Q · filed 2026-08-12 | $351.00K derived: sum of 3 quarters · filed 2026-08-12 | $457.00K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2026-03-31 | $109.00K 10-Q · filed 2026-05-12 | $240.00K derived: sum of 2 quarters · filed 2026-05-12 | $346.00K derived: sum of 3 quarters · filed 2026-05-12 | $434.00K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-12-31 | $131.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $237.00K derived: sum of 2 quarters · filed 2026-03-31 | $325.00K derived: sum of 3 quarters · filed 2026-08-12 | $400.00K 10-K · filed 2026-03-31 | |
| 2025-09-30 | $106.00K 10-Q · filed 2025-11-12 | $194.00K derived: sum of 2 quarters · filed 2026-08-12 | $269.00K 10-Q · filed 2025-11-12 | $345.00K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-06-30 | $88.00K 10-Q · filed 2026-08-12 | $163.00K 10-Q · filed 2026-08-12 | $239.00K derived: sum of 3 quarters · filed 2026-08-12 | $315.00K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-03-31 | $76.00K 10-Q · filed 2026-05-12 | $100.00K 10-Q · filed 2025-05-15 | $151.00K derived: sum of 2 quarters · filed 2026-05-12 | $227.00K derived: sum of 3 quarters · filed 2026-05-12 | $302.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $75.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $151.00K derived: sum of 2 quarters · filed 2026-03-31 | $226.00K derived: sum of 3 quarters · filed 2026-03-31 | $300.00K 10-K · filed 2026-03-31 | |
| 2024-09-30 | $76.00K 10-Q · filed 2025-11-12 | $151.00K derived: sum of 2 quarters · filed 2025-11-12 | $225.00K 10-Q · filed 2025-11-12 | ||
| 2024-06-30 | $75.00K 10-Q · filed 2025-08-13 | $149.00K 10-Q · filed 2025-08-13 | |||
| 2024-03-31 | $100.00K 10-Q · filed 2025-05-15 | ||||
| 2023-12-31 | $300.00K 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |